Who Owns Atossa Therapeutics Stock?
NASDAQ: ATOSHealthcareBiotechnologyUSD
At close: Oct 8, 4:00 PM ET · Delayed 15 min
Ownership breakdown
- Held by institutions
- 13.61%
- Held by insiders
- 1.85%
- Institutional holders
- 40
- Institutions 13.6%
- Insiders 1.8%
- Public and other 84.5%
Who owns Atossa Therapeutics stock?
Institutional investors own about 13.6% of Atossa Therapeutics's shares, spread across 40 institutions that file 13F reports. That level of institutional ownership is relatively low, leaving more of the stock with retail investors and insiders. Insiders, including executives, directors and large founding shareholders, hold 1.85% of ATOS.
The largest institutional holders are Vanguard Capital Management LLC (3.62%), Ameriprise Financial, Inc. (2.59%) and Blackrock Inc. (1.65%). Together, the top 10 institutions control 12.9% of shares outstanding. In their latest filings, 6 of the top 10 institutions increased their ATOS positions and 3 reduced them.
Summary generated from market data by MetaCap's automated system. Methodology
Top institutional holders of ATOS
| Institution | Shares | % Held | Change |
|---|---|---|---|
| Vanguard Capital Management LLC | 361.75K | 3.62% | +3.6% |
| Ameriprise Financial, Inc. | 258.23K | 2.59% | +1.2% |
| Blackrock Inc. | 164.36K | 1.65% | +23.4% |
| Renaissance Technologies, LLC | 132.04K | 1.32% | +21.1% |
| Geode Capital Management, LLC | 92.38K | 0.93% | -4.8% |
| UBS Group AG | 82.62K | 0.83% | -10.2% |
| Jane Street Group, LLC | 56.60K | 0.57% | +100.0% |
| Vanguard Fiduciary Trust Co | 52.58K | 0.53% | +0.7% |
| Millennium Management Llc | 46.51K | 0.47% | -30.3% |
| State Street Corporation | 39.76K | 0.40% | 0.0% |
% held is the share of total shares outstanding. Change is the percentage change in the position since the holder's previous 13F filing.
Top mutual fund and ETF holders of ATOS
| Fund | Shares | % Held |
|---|---|---|
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 256.14K | 2.57% |
| Columbia Funds Series Trust I-Columbia Small Cap Value Discovery Fund | 201.43K | 2.02% |
| VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund | 99.07K | 0.99% |
| Fidelity Concord Street Trust-Fidelity Extended Market Index Fund | 44.97K | 0.45% |
| Columbia Fd.s Varbl Insurance TRT-Columbia Varbl PORT. - Small Cap Val | 36.38K | 0.36% |
| iShares Trust-iShares Micro-Cap ETF | 29.01K | 0.29% |
| Fidelity Concord Street Trust-Fidelity Total Market Index Fund | 14.38K | 0.14% |
| Fidelity Concord Street Trust-Fidelity Series Total Market Index Fund | 12.64K | 0.13% |
| VANGUARD VALLEY FORGE FUNDS-Vanguard Balanced Index Fund | 6.54K | 0.07% |
| Fidelity Concord Street Trust-Fidelity Nasdaq Composite Index Fund | 4.91K | 0.05% |
Frequently asked questions
Who is the largest shareholder of Atossa Therapeutics?
Vanguard Capital Management LLC is the largest institutional shareholder of ATOS, owning 3.62% of shares outstanding (361.75K shares) as of its latest 13F filing.
What percentage of Atossa Therapeutics is owned by institutions?
Institutions own about 13.6% of ATOS shares and 13.9% of the public float.
How much of Atossa Therapeutics do insiders own?
Insiders, such as officers and directors, own about 1.85% of ATOS shares outstanding.
Where does institutional ownership data come from?
Investment managers with more than $100 million in US equities must file Form 13F with the SEC within 45 days of each quarter-end. Holdings are therefore up to about 4.5 months old when published.